Stryker Expands Foot & Ankle Portfolio with Synchfix EVT Launch
Event summary
- Stryker launched Synchfix EVT, a next-generation flexible syndesmotic fixation device, on February 24, 2026.
- The device features an all-in-one system with integrated suture tensioning handles and one-handed surgical deployment.
- Synchfix EVT is the first ankle syndesmotic flexible fixation device indicated for use in adolescents.
- The system received the Red Dot Design Award for its innovative design and procedural efficiency.
- Stryker will showcase Synchfix EVT at the 2026 ACFAS Annual Meeting.
The big picture
Stryker's launch of Synchfix EVT underscores its commitment to advancing foot and ankle care, particularly in complex syndesmotic injuries. The device's design innovations and expanded adolescent indication position it as a potential market differentiator in a competitive orthopedic landscape. The launch also highlights Stryker's strategy of leveraging surgeon feedback to drive product development, a tactic that has proven successful in its other business segments.
What we're watching
- Market Expansion
- Whether Stryker can leverage Synchfix EVT's adolescent indication to capture a larger share of the pediatric market.
- Competitive Dynamics
- How competitors like Zimmer Biomet and Arthrex will respond to Stryker's enhanced syndesmotic fixation offering.
- Adoption Pace
- The pace at which foot and ankle surgeons adopt Synchfix EVT, given its procedural efficiency and design awards.
Related topics